Información de la revista
Vol. 27. Núm. 7.
Páginas 429-430 (enero 2004)
Vol. 27. Núm. 7.
Páginas 429-430 (enero 2004)
Acceso a texto completo
Tumor estromal de localización gástrica
Visitas
3177
D. Sánchez-muñoz, E. Hoyas Pablos, M.V. Galán Jurado, P. Guerrero jiménez, M. Romero-gómez, M. Castro fernández
Servicio de Aparato Digestivo. Hospital Universitario de Valme. Sevilla. España
Contenido relacionado
Gastroenterol Hepatol. 2004;27:56010.1016/S0210-5705(03)70529-9
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Burkill, M. Badran, O. Al-Muderis, J.M. Thomas, I.R. Judson, C. Fisher, et al.
Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread.
Radiology, 226 (2003), pp. 527-532
[2.]
T. Hasegawa, Y. Matsuno, T. Shimoda, S. Hirohashi.
Gastrointestinal stromal tumor: consistent CD-117 immunostaining for diagnosis and prognostic classification based on tumor size and MIB-1 grade.
Hum Pathol, 33 (2002), pp. 669-676
[3.]
L.G. Kindblom, H.E. Remotti, F. Aldenborg, et al.
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.
Am J Pathol, 152 (1998), pp. 1259-1269
[4.]
M. Miettinen, J. Lasota.
Gastrointestinal stromal tumors. Definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis.
Virchows Arch, 438 (2001), pp. 1-12
[5.]
C. Fletcher, J.J. Berman, F. Gorstein, B.J. Longley, T.J. O'Leary, B.P. Rubin, et al.
Diagnosis of gastrointestinal stromal tumors: a consensus approach.
Hum Pathol, 33 (2002), pp. 459-465
[6.]
R.P. De Matteo, J.J. Lewis, D. Leung, et al.
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.
Ann Surg, 231 (2000), pp. 51-58
[7.]
M.H. Shiu, G.H. Farr, D.N. Papachristou, et al.
Myosarcomas of the stomach: natural history, prognostic factors and management.
Cancer, 49 (1982), pp. 177-187
[8.]
A.T. Van Oosterom, I. Judson, J. Verweij, et al.
Safety and efficacy of imatinib (STI-571) in metastatic gastrointestinal stromal tumors: a phase I study.
Lancet, 358 (2001), pp. 1421-1423
[9.]
M. O'Dwyer.
Current use of imatinib in the treatment of chronic myeloid leukemia.
Haematologica, 88 (2003), pp. 241-244
[10.]
M.R. Raspollini, A. Villanucci, G. Amunni, M. Paglierani, A. Taddei, G.L. Taddei.
C-Kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus.
J Chemother, 15 (2003), pp. 81-84
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados